Poly(γ-glutamic Acid)-coated Lipoplexes Loaded with Doxorubicin for Enhancing the Antitumor Activity Against Liver Tumors

Overview

Journal Nanoscale Res Lett

Publisher Springer

Specialty Biotechnology

Date 2017 May 24

PMID 28532126

Citations 7

Authors

Na Qi

Bo Tang

Guang Liu

Xingsi Liang

Affiliations

Soon will be listed here.

Abstract

The study was to develop poly-γ-glutamic acid (γ-PGA)-coated Doxorubicin (Dox) lipoplexes that enhance the antitumor activity against liver tumors. γ-PGA-coated lipoplexes were performed by electrostatistically attracting to the surface of cationic charge liposomes with anionic γ-PGA. With the increasing of γ-PGA concentration, the particle size of γ-PGA-coated Dox lipoplexes slightly increased, the zeta potential from positive shifted to negative, and the entrapment efficiency (EE) were no significant change. The release rate of γ-PGA-coated Dox lipoplexes slightly increased at acidic pH, the accelerated Dox release might be attributed to greater drug delivery to tumor cells, resulting in a higher antitumor activity. Especially, γ-PGA-coated Dox lipoplexes exhibited higher cellular uptake, significant in vitro cytotoxicity in HepG2 cells, and improved in vivo antitumor efficacy toward HepG2 hepatoma-xenografted nude models in comparison with Dox liposomes and free Dox solution. In addition, the analysis results via flow cytometry showed that γ-PGA-coated Dox lipoplexes induce S phase cell cycle arrest and significantly increased apoptosis rate of HepG2 cells. In conclusion, the presence of γ-PGA on the surface of Dox lipoplexes enhanced antitumor effects of liver tumors.

Citing Articles

Stimuli-Responsive Nanotechnology for RNA Delivery.

Zhou H, Chen D, Hu C, Hong X, Shi J, Xiao Y Adv Sci (Weinh). 2023; 10(36):e2303597.

PMID: 37915127 PMC: 10754096. DOI: 10.1002/advs.202303597.

Recent Advances in Poly(α--glutamic acid)-Based Nanomaterials for Drug Delivery.

Zhang Y, Song W, Lu Y, Xu Y, Wang C, Yu D Biomolecules. 2022; 12(5).

PMID: 35625562 PMC: 9138577. DOI: 10.3390/biom12050636.

Recent Advances and Challenges in Controlling the Spatiotemporal Release of Combinatorial Anticancer Drugs from Nanoparticles.

Yoon M, Lee Y, Shin H, Park C, Han S, Jung J Pharmaceutics. 2020; 12(12).

PMID: 33261219 PMC: 7759840. DOI: 10.3390/pharmaceutics12121156.

Cationic/Anionic Polyelectrolyte (PLL/PGA) Coated Vesicular Phospholipid Gels (VPGs) Loaded with Cytarabine for Sustained Release and Anti-glioma Effects.

Qi N, Zhang Y, Tang X, Li A Drug Des Devel Ther. 2020; 14:1825-1836.

PMID: 32494124 PMC: 7229786. DOI: 10.2147/DDDT.S248362.

Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma.

Kang S, Duan W, Zhang S, Chen D, Feng J, Qi N Theranostics. 2020; 10(10):4308-4322.

PMID: 32292496 PMC: 7150489. DOI: 10.7150/thno.41322.

References

Liu X, Wang J, Xu W, Ding J, Shi B, Huang K . Glutathione-degradable drug-loaded nanogel effectively and securely suppresses hepatoma in mouse model. Int J Nanomedicine. 2015; 10:6587-602. PMC: 4622485. DOI: 10.2147/IJN.S90000. View

Kaminskas L, McLeod V, Kelly B, Sberna G, Boyd B, Williamson M . A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems. Nanomedicine. 2011; 8(1):103-11. DOI: 10.1016/j.nano.2011.05.013. View

Qi N, Tang X, Lin X, Gu P, Cai C, Xu H . Sterilization stability of vesicular phospholipid gels loaded with cytarabine for brain implant. Int J Pharm. 2012; 427(2):234-41. DOI: 10.1016/j.ijpharm.2012.02.008. View

Hattori Y, Nakamura A, Arai S, Nishigaki M, Ohkura H, Kawano K . In vivo siRNA delivery system for targeting to the liver by poly-l-glutamic acid-coated lipoplex. Results Pharma Sci. 2015; 4:1-7. PMC: 4050376. DOI: 10.1016/j.rinphs.2014.01.001. View

Ding J, Xiao C, Li Y, Cheng Y, Wang N, He C . Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions. J Control Release. 2012; 169(3):193-203. DOI: 10.1016/j.jconrel.2012.12.006. View

Kurosaki T, Kitahara T, Fumoto S, Nishida K, Nakamura J, Niidome T . Ternary complexes of pDNA, polyethylenimine, and gamma-polyglutamic acid for gene delivery systems. Biomaterials. 2009; 30(14):2846-53. DOI: 10.1016/j.biomaterials.2009.01.055. View

Endo I, Gonen M, Yopp A, Dalal K, Zhou Q, Klimstra D . Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008; 248(1):84-96. DOI: 10.1097/SLA.0b013e318176c4d3. View

Kurosaki T, Kitahara T, Kawakami S, Higuchi Y, Yamaguchi A, Nakagawa H . Gamma-polyglutamic acid-coated vectors for effective and safe gene therapy. J Control Release. 2009; 142(3):404-10. DOI: 10.1016/j.jconrel.2009.11.010. View

Working P, NEWMAN M, Sullivan T, Yarrington J . Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. J Pharmacol Exp Ther. 1999; 289(2):1128-33. View

10.

Ding J, Xu W, Zhang Y, Sun D, Xiao C, Liu D . Self-reinforced endocytoses of smart polypeptide nanogels for "on-demand" drug delivery. J Control Release. 2013; 172(2):444-55. DOI: 10.1016/j.jconrel.2013.05.029. View

11.

Smith L, Cornelius V, Plummer C, Levitt G, Verrill M, Canney P . Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer. 2010; 10:337. PMC: 2907344. DOI: 10.1186/1471-2407-10-337. View

12.

Zhang C, Wang W, Liu T, Wu Y, Guo H, Wang P . Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. Biomaterials. 2011; 33(7):2187-96. DOI: 10.1016/j.biomaterials.2011.11.045. View

13.

Li D, Sun H, Ding J, Tang Z, Zhang Y, Xu W . Polymeric topology and composition constrained polyether-polyester micelles for directional antitumor drug delivery. Acta Biomater. 2013; 9(11):8875-84. DOI: 10.1016/j.actbio.2013.06.041. View

14.

Pommier Y, Leo E, Zhang H, Marchand C . DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol. 2010; 17(5):421-33. PMC: 7316379. DOI: 10.1016/j.chembiol.2010.04.012. View

15.

Ding J, Shi F, Li D, Chen L, Zhuang X, Chen X . Enhanced endocytosis of acid-sensitive doxorubicin derivatives with intelligent nanogel for improved security and efficacy. Biomater Sci. 2020; 1(6):633-646. DOI: 10.1039/c3bm60024f. View

16.

Takakura Y, Nishikawa M, Yamashita F, Hashida M . Influence of physicochemical properties on pharmacokinetics of non-viral vectors for gene delivery. J Drug Target. 2002; 10(2):99-104. DOI: 10.1080/10611860290016694. View

17.

Cutts S, Swift L, Rephaeli A, Nudelman A, Phillips D . Sequence specificity of adriamycin-DNA adducts in human tumor cells. Mol Cancer Ther. 2003; 2(7):661-70. View

18.

Lila A, Kizuki S, Doi Y, Suzuki T, Ishida T, Kiwada H . Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. J Control Release. 2009; 137(1):8-14. DOI: 10.1016/j.jconrel.2009.02.023. View

19.

Kim J, Yoon I, Cho H, Kim D, Choi Y, Kim D . Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: improved intestinal paracellular absorption and alleviated cardiotoxicity. Int J Pharm. 2014; 464(1-2):117-26. DOI: 10.1016/j.ijpharm.2014.01.016. View

20.

Yao J, Fan Y, Du R, Zhou J, Lu Y, Wang W . Amphoteric hyaluronic acid derivative for targeting gene delivery. Biomaterials. 2010; 31(35):9357-65. DOI: 10.1016/j.biomaterials.2010.08.043. View